Results 101 to 110 of about 198,891 (298)
Intranasal ciclesonide for allergic rhinitis
, 2008 Ben Williams, William B Smith, Frank E KetteDepartment of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, South AustraliaAbstract: Ciclesonide is a novel corticosteroid which is optimized for topical use.
Ben Williams +2 more
core
, 2016 Background: Allergic rhinitis (AR) is a chronic systemic allergic disease with an association reported between allergy and anxiety. The objective of the current study was therefore to investigate and retrospectively evaluate the factors that may ...
Xi, Lin +7 more
core +1 more source
Pediatric Investigation, EarlyView.This review synthesizes epidemiological evidence linking atopic dermatitis to attention‐deficit/hyperactivity disorder in children, proposes an “inflammation‐itch‐neurobehavioral axis” integrating sleep disruption, neuroendocrine dysregulation, and emerging neuro‐immune circuits, and outlines multidisciplinary management strategies targeting both skin ...
Qingyang Zhao +11 more
wiley +1 more source
PLANTS, PEOPLE, PLANET, EarlyView.Pollen allergies are a primary cause of seasonal allergic rhinitis, which affects over 500 million people globally, damaging quality of life and incurring significant costs in medical treatment and reduced work productivity. Many countries monitor pollen to inform allergy sufferers about seasonal pollen levels.
David R. Williamson +6 more
wiley +1 more source
Journal of Mazandaran University of Medical Sciences, 2019 Background and purpose: Allergic rhinitis is a common disease in different parts of the world. It can cause deterioration of symptoms of comorbid diseases and has harmful effects on daily activities and social functions of patients. The aim of this study
Mir Mohammad Jalali +3 more
doaj
Pest Management Science, EarlyView.Field‐collected Ambrosia artemisiifolia populations from Michigan, USA, soybean fields exhibited strong resistance to the protoporphyrinogen IX oxidase (PPO)‐inhibiting herbicide sulfentrazone and reduced sensitivity to fomesafen. Target‐site analysis identified a novel Arg‐98‐Gln (R98Q) substitution in PPO2, co‐occurring with the previously reported ...
Sara Álvarez‐Rodríguez +4 more
wiley +1 more source
Phytotherapy Research, EarlyView.ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit +5 more
wiley +1 more source
Phytotherapy Research, EarlyView.Overview of systematic reviews evaluating the benefits and harms of herbal medicines for management of ARIs. ABSTRACT Hundreds of herbal medicines are currently marketed for the management of acute respiratory infections (ARIs). However, there is uncertainty about their benefits and harms, and clinical guidance remains unclear.
Fariba Aghajafari +11 more
wiley +1 more source
A Survey on Seasonal Symptoms in Subjects with and Without Allergic Rhinitis Diagnosis
In Switzerland, only scarce data are available on the prevalence and treatment of allergic rhinitis. Although the presence of AR symptoms in temporal relation to the respective aeroallergen is indicative, still a substantial number of affected ...
Victor Colin +6 more
core +1 more source
Allergic rhinitis characteristics.
, 2019 Allergic rhinitis characteristics.
Abdulmohsin A. Almehizia (6882782) +7 more
core +1 more source